Earnings Call · Q3 FY2023·2023-11-08

Q3 23EPS +14.55%·Rev n/aQ2 23EPS +3.70%·Rev n/aQ1 23EPS +6.84%·Rev n/aQ4 22EPS +13.08%·Rev n/a⚠ consensus missing

Arcus Biosciences, Inc. RCUS

Pia Eaves — Head of Investor Relations

Terry Rosen — Chief Executive Officer

Dimitry Nuyten — Chief Medical Officer

Jennifer Jarrett — Head of Clinical Development

Robert Goeltz — Chief Financial Officer

−2.7%1d on move date−2.7% vs SPY3d−17.7%5d−12.5%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RCUS calls or request research access.

More RCUS calls Browse calls Request research access